Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05563376
NA

Fontan-Sprechstunde

Sponsor: University of Erlangen-Nürnberg Medical School

View on ClinicalTrials.gov

Summary

After successful Fontan surgery, the risk of mortality in childhood is only low. Unfortunately, some of the patients suffer from Fontan-typical long-term complications in the long-term course, whereby protein loss neuropathy must be mentioned in particular, which is described in the literature with an incidence of 3-14% (1, 2) and still has a 5-year risk of death of 6-12% today (2, 3). Protein loss tereopathy leads to loss of protein in the intestine and subsequently to diarrhea and edema. Other problems concern the liver, which can develop cirrhosis due to chronic congestion (4-6). Cardiac can lead to heart failure and arrhythmias. The registry study described in this protocol is intended to identify factors that influence the treatment outcome of patients in the Fontan circulation in the long term through systematic prospective documentation of the data from our standardized and guideline-oriented treatment.

Official title: Prospektive Erfassung Von standardmäßig Erhobenen Daten im Rahmen Der Erlanger Fontan-Sprechstunde Zur Behandlung Und Überwachung Von PatientInnen Mit univentrikulärem Herzfehler im Sinne Einer Fontan-Zirkulation

Key Details

Gender

All

Age Range

6 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2020-09-01

Completion Date

2041-09-01

Last Updated

2022-10-03

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Univentricular Hearts

Prevention when factors are recognized

Locations (1)

Universitätsklinikum

Erlangen, Germany